Patents by Inventor Vanesa Fernandez-Saiz

Vanesa Fernandez-Saiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases
    Patent number: 10987345
    Abstract: The invention relates to a combination of an immunomodulatory imide drug (IMiD) and an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a subject. It further relates to an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a patient, wherein the patient is IMiD resistant. It further relates to a method of monitoring the efficacy of an IMiD treatment regimen by comparing the protein level of CD147 and/or MCT1 in samples obtained from a subject prior and during IMiD treatment.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: April 27, 2021
    Assignee: Klinikum Rechts Der Isar Der Technischen Universität München
    Inventors: Florian Bassermann, Ruth Eichner, Vanesa Fernandez-Saiz
  • Method for Assessing the Efficacy of IMIDS and Composition or Combination for Use in Treating IMID Sensitive Diseases
    Publication number: 20200016144
    Abstract: The invention relates to a combination of an immunomodulatory imide drug (IMiD) and an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a subject. It further relates to an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a patient, wherein the patient is IMiD resistant. It further relates to a method of monitoring the efficacy of an IMiD treatment regimen by comparing the protein level of CD147 and/or MCT1 in samples obtained from a subject prior and during IMiD treatment.
    Type: Application
    Filed: July 18, 2019
    Publication date: January 16, 2020
    Applicant: Klinikum Rechts Der Isar Der Technischen Universitat Munchen
    Inventors: Florian Bassermann, Ruth Eichner, Vanesa Fernandez-Saiz
  • Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases
    Patent number: 10398688
    Abstract: The invention relates to a combination of an immunomodulatory imide drug (IMiD) and an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a subject. It further relates to an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a patient, wherein the patient is IMiD resistant. It further relates to a method of monitoring the efficacy of an IMiD treatment regimen by comparing the protein level of CD147 and/or MCT1 in samples obtained from a subject prior and during IMiD treatment.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: September 3, 2019
    Assignee: KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MÜNCHEN
    Inventors: Florian Bassermann, Ruth Eichner, Vanesa Fernandez-Saiz
  • Method for Assessing the Efficacy of IMIDS and Composition or Combination for Use in Treating IMID Sensitive Diseases
    Publication number: 20170296524
    Abstract: The invention relates to a combination of an immunomodulatory imide drug (IMiD) and an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a subject. It further relates to an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a disease in a patient, wherein the patient is IMiD resistant. It further relates to a method of monitoring the efficacy of an IMiD treatment regimen by comparing the protein level of CD147 and/or MCT1 in samples obtained from a subject prior and during IMiD treatment.
    Type: Application
    Filed: September 23, 2015
    Publication date: October 19, 2017
    Inventors: Florian Bassermann, Ruth Eichner, Vanesa Fernandez-Saiz